SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,382.50 -256.53
( -0.33%)

Global Indices

Nasdaq

53,210.99 704.96
(1.34%)

Dow Jones

7,621.51 110.79
(1.48%)

Hang Seng

63,983.92 229.02
(0.36%)

Nikkei 225

10,850.37 -17.68
(-0.16%)

Forex

USD-INR

95.40 -0.19
(-0.20%)

EUR-INR

110.00 0.21
(0.19%)

GBP-INR

128.60 0.50
(0.39%)

JPY-INR

0.61 0.01
(2.47%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3864135

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

20.92

141.22

EPS(TTM)

Face Value()

Div & Yield %

4.24

1.35

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	302.50	338.54	303.10	280.37	249.31	170.67
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	302.50	338.54	303.10	280.37	249.31	170.67
Other Income	2.15	2.30	2.19	6.49	2.69	3.63
Stock Adjustments	7.08	1.06	17.90	4.85	-5.13	-3.32
Total Income	311.73	341.90	323.19	291.71	246.87	170.98
EXPENDITURE :
Raw Materials	164.85	192.80	187.83	171.35	145.45	81.39
Power & Fuel Cost	8.29	8.73	6.87	5.37	4.70	4.68
Employee Cost	61.83	59.57	51.56	44.46	39.62	48.78
Other Manufacturing Expenses	10.70	12.95	20.20	14.64	9.12	7.07
Selling & Administrative Expenses	33.21	32.27	26.21	21.64	15.44	17.59
Miscellaneous Expenses	0.42	1.56	1.90	4.35	3.24	0.82
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	279.30	307.89	294.56	261.82	217.57	160.34
Operating Profit	32.42	34.01	28.62	29.89	29.30	10.64
Interest	17.04	14.64	12.59	10.60	12.25	12.69
Gross Profit	15.38	19.37	16.03	19.29	17.05	-2.05
Depreciation	9.65	10.05	7.48	7.24	7.26	7.03
Profit Before Tax	5.73	9.32	8.55	12.05	9.79	-9.08
Tax	-0.14	0.76	2.03	5.42	0.38	-0.15
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.93	0.84	0.39	-1.94	0.32	-0.03
Reported Net Profit	7.80	7.73	6.13	8.58	9.10	-8.90
Extraordinary Items	0.00	0.05	0.03	0.78	0.04	0.00
Adjusted Net Profit	7.80	7.68	6.10	7.80	9.06	-8.90
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-0.29
P & L Balance brought forward	42.90	36.74	42.37	35.27	26.18	36.79
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.91	1.57	1.56	1.48	0.00	1.42
P & L Balance carried down	48.79	42.90	46.94	42.37	35.27	26.17
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	12.00	12.00	10.00	10.00	10.00	0.00
Dividend Per Share(Rs)	1.20	1.20	1.00	1.00	1.00	0.00
Earnings Per Share-Unit Curr	4.90	4.89	3.90	5.79	6.14	-6.28
Earnings Per Share(Adj)-Unit Curr	4.90	4.89	3.90	5.79	6.14	-6.28
Book Value-Unit Curr	62.07	58.74	61.21	58.28	52.88	46.53
Book Value(Adj)-Unit Curr	62.07	58.74	61.21	58.28	52.88	46.53

78,382.50 -256.53 ( -0.33%)

53,210.99 704.96 (1.34%)

7,621.51 110.79 (1.48%)

63,983.92 229.02 (0.36%)

10,850.37 -17.68 (-0.16%)

95.40 -0.19 (-0.20%)

110.00 0.21 (0.19%)

128.60 0.50 (0.39%)

0.61 0.01 (2.47%)